• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Parkin 抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨丢失。

Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss.

机构信息

Department of Orthopedics, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.

Research Institute of Orthopedics, Zhejiang University, Hangzhou 310009, China.

出版信息

Biomolecules. 2022 Oct 31;12(11):1602. doi: 10.3390/biom12111602.

DOI:10.3390/biom12111602
PMID:36358952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9687699/
Abstract

Osteoporosis and osteoporotic fractures comprise a substantial health and socioeconomic burden. The leading cause of osteoporosis is an imbalance in bone formation and bone resorption caused by hyperactive osteoclasts. Therefore, a new strategy to suppress osteoclastogenesis is needed. Parkin is likely closely associated with bone metabolism, although its role in osteoclastogenesis is unclear. In this study, the Parkin protein inhibited the receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation, osteoclast-specific gene expression, F-actin ring formation, and bone resorption pit formation in vitro. Moreover, depletion of Parkin enhanced RANKL-induced osteoclast formation, osteoclast-specific gene expression, F-actin ring formation, and bone resorption pit formation. Reactive oxygen species (ROS) activity was suppressed, while autophagy was upregulated with the presence of the Parkin protein. ROS activity was upregulated and autophagy was decreased due to Parkin knockdown. In addition, intravenous administration of Parkin rescued ovariectomy-induced bone loss and reduced osteoclastogenesis in vivo. Collectively, Parkin has therapeutic potential for diseases associated with overactive osteoclasts.

摘要

骨质疏松症和骨质疏松性骨折给健康和社会经济带来了巨大的负担。骨质疏松症的主要原因是破骨细胞过度活跃导致的骨形成和骨吸收失衡。因此,需要一种新的抑制破骨细胞生成的策略。Parkin 可能与骨代谢密切相关,但其在破骨细胞生成中的作用尚不清楚。在这项研究中,Parkin 蛋白抑制了核因子-κB 配体(RANKL)诱导的体外破骨细胞形成、破骨细胞特异性基因表达、F-actin 环形成和骨吸收陷窝形成。此外,Parkin 耗竭增强了 RANKL 诱导的破骨细胞形成、破骨细胞特异性基因表达、F-actin 环形成和骨吸收陷窝形成。Parkin 蛋白存在时,活性氧(ROS)活性受到抑制,自噬上调。由于 Parkin 敲低,ROS 活性上调,自噬减少。此外,静脉给予 Parkin 可挽救去卵巢诱导的骨丢失,并减少体内的破骨细胞生成。综上所述,Parkin 具有治疗与过度活跃的破骨细胞相关疾病的潜力。

相似文献

1
Parkin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss.Parkin 抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨丢失。
Biomolecules. 2022 Oct 31;12(11):1602. doi: 10.3390/biom12111602.
2
Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.白杨素 A 通过抑制 NF-κB 和 Akt 通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
J Ethnopharmacol. 2021 Aug 10;276:114176. doi: 10.1016/j.jep.2021.114176. Epub 2021 Apr 30.
3
Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.长春西汀抑制 RANKL 诱导的破骨细胞生成,并减轻卵巢切除诱导的骨丢失。
Biomed Pharmacother. 2020 Mar;123:109769. doi: 10.1016/j.biopha.2019.109769. Epub 2019 Dec 15.
4
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
5
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.马粟酸通过调节 RANKL 介导的 NF-κB 和 MAPK 信号通路抑制破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.
6
Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.冬凌草甲素通过抑制 ROS 介导的 NF-κB 和 NFATc1 活性减轻去卵巢诱导的骨丢失和 RANKL 诱导的破骨细胞形成。
Phytomedicine. 2024 Jul;129:155559. doi: 10.1016/j.phymed.2024.155559. Epub 2024 Mar 20.
7
Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.佛手柑内酯通过抑制 NF-κB 和 JNK 信号通路抑制 RANKL 诱导的破骨细胞生成和卵巢切除诱导的骨质疏松症。
Biochem Biophys Res Commun. 2019 Feb 5;509(2):329-334. doi: 10.1016/j.bbrc.2018.12.112. Epub 2018 Dec 20.
8
Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways.兵豆素通过抑制破骨细胞形成和 RANKL 诱导的信号通路抑制骨质疏松症。
J Cell Physiol. 2019 Jul;234(7):11792-11804. doi: 10.1002/jcp.27868. Epub 2018 Dec 4.
9
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss.菊苣酸靶向 RANKL 抑制破骨细胞生成并预防卵巢切除诱导的骨丢失。
Phytother Res. 2024 Apr;38(4):1971-1989. doi: 10.1002/ptr.8141. Epub 2024 Feb 15.
10
Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.花椒毒素通过抑制核因子κB受体活化因子配体(RANKL)诱导的破骨细胞生成来预防去卵巢小鼠的骨质流失。
Osteoporos Int. 2016 Jul;27(7):2335-2344. doi: 10.1007/s00198-016-3496-8. Epub 2016 Jan 25.

本文引用的文献

1
An Antioxidant Sesquiterpene Inhibits Osteoclastogenesis Via Blocking IPMK/TRAF6 and Counteracts OVX-Induced Osteoporosis in Mice.一种抗氧化倍半萜通过抑制 IPMK/TRAF6 抑制破骨细胞生成,并在去卵巢小鼠中对抗骨质疏松症。
J Bone Miner Res. 2021 Sep;36(9):1850-1865. doi: 10.1002/jbmr.4328. Epub 2021 May 18.
2
Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis.缺氧抑制 RANKL 诱导的铁蛋白自噬,保护破骨细胞免于铁死亡。
Free Radic Biol Med. 2021 Jun;169:271-282. doi: 10.1016/j.freeradbiomed.2021.04.027. Epub 2021 Apr 22.
3
Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis.
挖掘纳米酶的生物活性以重塑微环境,保护软骨细胞并延缓骨关节炎。
Bioact Mater. 2021 Jan 29;6(8):2439-2451. doi: 10.1016/j.bioactmat.2021.01.016. eCollection 2021 Aug.
4
Improved prediction of fracture risk leveraging a genome-wide polygenic risk score.利用全基因组多基因风险评分提高骨折风险预测能力。
Genome Med. 2021 Feb 3;13(1):16. doi: 10.1186/s13073-021-00838-6.
5
Osteoporosis: overlooked in men for too long.骨质疏松症:在男性中被忽视太久了。
Lancet Diabetes Endocrinol. 2021 Jan;9(1):1. doi: 10.1016/S2213-8587(20)30408-3. Epub 2020 Dec 4.
6
Upregulation of Parkin Accelerates Osteoblastic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and Bone Regeneration by Enhancing Autophagy and β-Catenin Signaling.帕金蛋白的上调通过增强自噬和β-连环蛋白信号通路加速骨髓间充质干细胞的成骨分化和骨再生。
Front Cell Dev Biol. 2020 Sep 15;8:576104. doi: 10.3389/fcell.2020.576104. eCollection 2020.
7
The Role of Autophagy in Osteoclast Differentiation and Bone Resorption Function.自噬在破骨细胞分化和骨吸收功能中的作用。
Biomolecules. 2020 Sep 30;10(10):1398. doi: 10.3390/biom10101398.
8
The Role of Autophagy and Mitophagy in Bone Metabolic Disorders.自噬和线粒体自噬在骨代谢紊乱中的作用。
Int J Biol Sci. 2020 Jul 30;16(14):2675-2691. doi: 10.7150/ijbs.46627. eCollection 2020.
9
Transcriptome Analysis Reveals That Nakai Extract Inhibits RANKL-Mediated Osteoclastogenensis Mainly Through Suppressing Nfatc1 Expression.转录组分析表明,中井提取物主要通过抑制Nfatc1表达来抑制RANKL介导的破骨细胞生成。
Biology (Basel). 2020 Aug 6;9(8):212. doi: 10.3390/biology9080212.
10
3-Hydroxyolean-12-en-27-oic Acids Inhibit RANKL-Induced Osteoclastogenesis in Vitro and Inflammation-Induced Bone Loss in Vivo.3-羟基齐墩果-12-烯-27-酸在体外抑制 RANKL 诱导的破骨细胞生成和体内炎症诱导的骨丢失。
Int J Mol Sci. 2020 Jul 23;21(15):5240. doi: 10.3390/ijms21155240.